Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Baxter
Merck
Medtronic
Mallinckrodt

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for AstraZeneca AB v. Watson Laboratories Inc. (D. Del. 2014)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in AstraZeneca AB v. Watson Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for AstraZeneca AB v. Watson Laboratories Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-05-23 1 product, prior to expiration of U.S. Patent No. 7,951,400 (“the ’400 patent”). ME1 17953993v.2 Case … This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 17. On May 31, 2011, the U.S. Patent and Trademark Office…copy of the ’400 patent is attached hereto as Exhibit A. The claims of the ’400 patent are valid and enforceable…includes ONGLYZA® together with the ’400 patent and U.S. Patent No. RE44,186, which covers the composition External link to document
2014-09-23 16 than April 10, 2014. Date of Expiration of Patent: 7,951,400 (November 30, 2028).Thirty Month Stay Deadline… Amended Supplemental information for patent cases involving an Abbreviated New Drug Application…2014 16 April 2015 1:14-cv-00666 830 Patent Defendant District Court, D. External link to document
2014-05-23 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,951,400. (rwc) (Entered: 05…2014 16 April 2015 1:14-cv-00666 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Moodys
Merck
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.